Akili, Inc. (NASDAQ: AKLI) Stock Competitors & Peer Comparison
See AKLI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AKLI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AKLI | $0.43 | +0.25% | 34.1M | -0.71 | -$0.61 | N/A |
| GEHC | $73.79 | +2.09% | 33.3B | 16.18 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $60.23 | +0.92% | 11.8B | 48.57 | $1.24 | N/A |
| TEM | $54.29 | -0.59% | 9.5B | -108.58 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.59 | +0.09% | 8.8B | 24.67 | $4.28 | N/A |
| TXG | $58.15 | +0.69% | 7.4B | -342.06 | -$0.17 | N/A |
| HNGE | $87.42 | +1.27% | 6.8B | 46.68 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
AKLI vs GEHC Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, GEHC has a market cap of 33.3B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while GEHC trades at $73.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas GEHC's P/E ratio is 16.18. In terms of profitability, AKLI's ROE is -0.70%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, AKLI is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
AKLI vs GEHCV Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas GEHCV's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, AKLI is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
AKLI vs BTSG Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, BTSG has a market cap of 11.8B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while BTSG trades at $60.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas BTSG's P/E ratio is 48.57. In terms of profitability, AKLI's ROE is -0.70%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, AKLI is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
AKLI vs TEM Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, TEM has a market cap of 9.5B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while TEM trades at $54.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas TEM's P/E ratio is -108.58. In terms of profitability, AKLI's ROE is -0.70%, compared to TEM's ROE of -0.55%. Regarding short-term risk, AKLI is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
AKLI vs SGFY Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SGFY's P/E ratio is 70.91. In terms of profitability, AKLI's ROE is -0.70%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, AKLI is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
AKLI vs HQY Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while HQY trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas HQY's P/E ratio is 24.67. In terms of profitability, AKLI's ROE is -0.70%, compared to HQY's ROE of +0.11%. Regarding short-term risk, AKLI is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
AKLI vs TXG Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, TXG has a market cap of 7.4B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while TXG trades at $58.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas TXG's P/E ratio is -342.06. In terms of profitability, AKLI's ROE is -0.70%, compared to TXG's ROE of -0.09%. Regarding short-term risk, AKLI is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
AKLI vs HNGE Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while HNGE trades at $87.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas HNGE's P/E ratio is 46.68. In terms of profitability, AKLI's ROE is -0.70%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, AKLI is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
AKLI vs RCM Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas RCM's P/E ratio is -102.21. In terms of profitability, AKLI's ROE is -0.70%, compared to RCM's ROE of +0.00%. Regarding short-term risk, AKLI is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
AKLI vs DOCS Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while DOCS trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas DOCS's P/E ratio is 17.38. In terms of profitability, AKLI's ROE is -0.70%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, AKLI is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
AKLI vs WAY Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while WAY trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas WAY's P/E ratio is 16.61. In terms of profitability, AKLI's ROE is -0.70%, compared to WAY's ROE of +0.04%. Regarding short-term risk, AKLI is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check WAY's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
AKLI vs ONEM Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ONEM's P/E ratio is -7.77. In terms of profitability, AKLI's ROE is -0.70%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, AKLI is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
AKLI vs PRVA Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while PRVA trades at $21.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas PRVA's P/E ratio is 103.62. In terms of profitability, AKLI's ROE is -0.70%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, AKLI is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
AKLI vs HTFL Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, HTFL has a market cap of 2.7B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while HTFL trades at $31.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas HTFL's P/E ratio is -15.43. In terms of profitability, AKLI's ROE is -0.70%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, AKLI is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
AKLI vs WGS Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, WGS has a market cap of 2.4B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while WGS trades at $79.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas WGS's P/E ratio is 219.86. In terms of profitability, AKLI's ROE is -0.70%, compared to WGS's ROE of -0.39%. Regarding short-term risk, AKLI is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
AKLI vs PGNY Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while PGNY trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas PGNY's P/E ratio is 18.76. In terms of profitability, AKLI's ROE is -0.70%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, AKLI is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check PGNY's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
AKLI vs NXGN Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas NXGN's P/E ratio is -266.00. In terms of profitability, AKLI's ROE is -0.70%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, AKLI is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
AKLI vs OMDA Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while OMDA trades at $24.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas OMDA's P/E ratio is 348.14. In terms of profitability, AKLI's ROE is -0.70%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, AKLI is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
AKLI vs AGTI Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas AGTI's P/E ratio is -71.79. In terms of profitability, AKLI's ROE is -0.70%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, AKLI is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
AKLI vs GDRX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while GDRX trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas GDRX's P/E ratio is 11.63. In terms of profitability, AKLI's ROE is -0.70%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, AKLI is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
AKLI vs CERT Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CERT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CERT's P/E ratio is 20.38. In terms of profitability, AKLI's ROE is -0.70%, compared to CERT's ROE of -0.07%. Regarding short-term risk, AKLI is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CERT's competition here
Teladoc Health, Inc. (NYSE: TDOC)
AKLI vs TDOC Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while TDOC trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas TDOC's P/E ratio is -7.72. In terms of profitability, AKLI's ROE is -0.70%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, AKLI is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
AKLI vs CCLDO Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CCLDO's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, AKLI is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
AKLI vs HSTM Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, HSTM has a market cap of 847.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while HSTM trades at $29.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas HSTM's P/E ratio is 35.83. In terms of profitability, AKLI's ROE is -0.70%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, AKLI is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
AKLI vs PHR Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, PHR has a market cap of 779.4M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while PHR trades at $12.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas PHR's P/E ratio is 45.04. In terms of profitability, AKLI's ROE is -0.70%, compared to PHR's ROE of +0.03%. Regarding short-term risk, AKLI is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check PHR's competition here
Claritev Corporation (NYSE: CTEV)
AKLI vs CTEV Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CTEV has a market cap of 719.4M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CTEV trades at $42.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CTEV's P/E ratio is -2.48. In terms of profitability, AKLI's ROE is -0.70%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, AKLI is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CTEV's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
AKLI vs SOPH Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SOPH has a market cap of 639.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SOPH trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SOPH's P/E ratio is -6.86. In terms of profitability, AKLI's ROE is -0.70%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, AKLI is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
AKLI vs MPLN-WT Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, AKLI is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
AKLI vs ACCD Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ACCD's P/E ratio is -3.08. In terms of profitability, AKLI's ROE is -0.70%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, AKLI is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
AKLI vs SHCR Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SHCR's P/E ratio is -3.76. In terms of profitability, AKLI's ROE is -0.70%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, AKLI is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
AKLI vs EVH Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, EVH has a market cap of 525.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while EVH trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas EVH's P/E ratio is 35.92. In terms of profitability, AKLI's ROE is -0.70%, compared to EVH's ROE of -0.99%. Regarding short-term risk, AKLI is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check EVH's competition here
NRC Health (NASDAQ: NRC)
AKLI vs NRC Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, NRC has a market cap of 480.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while NRC trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas NRC's P/E ratio is 25.99. In terms of profitability, AKLI's ROE is -0.70%, compared to NRC's ROE of +0.48%. Regarding short-term risk, AKLI is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
AKLI vs SLGC Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SLGC's P/E ratio is -3.04. In terms of profitability, AKLI's ROE is -0.70%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, AKLI is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
AKLI vs SLGCW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, AKLI's ROE is -0.70%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, AKLI is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
AKLI vs TBRG Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas TBRG's P/E ratio is 9.37. In terms of profitability, AKLI's ROE is -0.70%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, AKLI is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
AKLI vs MPLN Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MPLN's P/E ratio is -0.23. In terms of profitability, AKLI's ROE is -0.70%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, AKLI is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
AKLI vs SY Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SY has a market cap of 288.7M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SY trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SY's P/E ratio is -6.67. In terms of profitability, AKLI's ROE is -0.70%, compared to SY's ROE of -0.16%. Regarding short-term risk, AKLI is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
AKLI vs TRHC Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas TRHC's P/E ratio is -4.27. In terms of profitability, AKLI's ROE is -0.70%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, AKLI is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
AKLI vs SMFR Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SMFR's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, AKLI is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
AKLI vs SPOK Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SPOK has a market cap of 229.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SPOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SPOK's P/E ratio is 18.33. In terms of profitability, AKLI's ROE is -0.70%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, AKLI is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
AKLI vs AMWL Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, AMWL has a market cap of 219.9M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while AMWL trades at $12.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas AMWL's P/E ratio is -2.93. In terms of profitability, AKLI's ROE is -0.70%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, AKLI is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
AKLI vs OPRX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, OPRX has a market cap of 164.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while OPRX trades at $8.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas OPRX's P/E ratio is 8.06. In terms of profitability, AKLI's ROE is -0.70%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, AKLI is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
AKLI vs CPSI Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CPSI's P/E ratio is -183.80. In terms of profitability, AKLI's ROE is -0.70%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, AKLI is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
AKLI vs HCAT Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, HCAT has a market cap of 129.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while HCAT trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas HCAT's P/E ratio is 8.75. In terms of profitability, AKLI's ROE is -0.70%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, AKLI is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
AKLI vs AUGX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas AUGX's P/E ratio is -4.99. In terms of profitability, AKLI's ROE is -0.70%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, AKLI is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
AKLI vs CCLD Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CCLD's P/E ratio is 9.42. In terms of profitability, AKLI's ROE is -0.70%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, AKLI is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
AKLI vs WORX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas WORX's P/E ratio is -6.40. In terms of profitability, AKLI's ROE is -0.70%, compared to WORX's ROE of -0.65%. Regarding short-term risk, AKLI is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
AKLI vs FORA Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas FORA's P/E ratio is -24.11. In terms of profitability, AKLI's ROE is -0.70%, compared to FORA's ROE of -0.17%. Regarding short-term risk, AKLI is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check FORA's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
AKLI vs DH Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, DH has a market cap of 67.6M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while DH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas DH's P/E ratio is 2.46. In terms of profitability, AKLI's ROE is -0.70%, compared to DH's ROE of -0.75%. Regarding short-term risk, AKLI is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
AKLI vs CCLDP Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CCLDP's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, AKLI is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
AKLI vs ONMD Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ONMD has a market cap of 44.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ONMD trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ONMD's P/E ratio is -5.18. In terms of profitability, AKLI's ROE is -0.70%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, AKLI is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
AKLI vs SNCE Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SNCE's P/E ratio is -0.27. In terms of profitability, AKLI's ROE is -0.70%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, AKLI is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check SNCE's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
AKLI vs SHLT Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SHLT's P/E ratio is -3.87. In terms of profitability, AKLI's ROE is -0.70%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, AKLI is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
AKLI vs SHCRW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, AKLI's ROE is -0.70%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, AKLI is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
AKLI vs ONMDW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ONMDW's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, AKLI is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
AKLI vs STRM Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas STRM's P/E ratio is -2.40. In terms of profitability, AKLI's ROE is -0.70%, compared to STRM's ROE of -0.65%. Regarding short-term risk, AKLI is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
AKLI vs RNLX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas RNLX's P/E ratio is -0.33. In terms of profitability, AKLI's ROE is -0.70%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, AKLI is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
AKLI vs LIFW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas LIFW's P/E ratio is -0.02. In terms of profitability, AKLI's ROE is -0.70%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, AKLI is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
AKLI vs SCNX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SCNX has a market cap of 18.9M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SCNX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SCNX's P/E ratio is -0.19. In terms of profitability, AKLI's ROE is -0.70%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, AKLI is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
AKLI vs BBLN Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas BBLN's P/E ratio is -0.04. In terms of profitability, AKLI's ROE is -0.70%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, AKLI is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
AKLI vs BEATW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, BEATW has a market cap of 12.5M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas BEATW's P/E ratio is -0.03. In terms of profitability, AKLI's ROE is -0.70%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, AKLI is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
AKLI vs BFRG Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas BFRG's P/E ratio is -1.08. In terms of profitability, AKLI's ROE is -0.70%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, AKLI is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
AKLI vs ETAO Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ETAO's P/E ratio is -0.01. In terms of profitability, AKLI's ROE is -0.70%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, AKLI is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
AKLI vs MGRX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MGRX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MGRX's P/E ratio is -0.39. In terms of profitability, AKLI's ROE is -0.70%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, AKLI is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
AKLI vs UPH Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas UPH's P/E ratio is -0.07. In terms of profitability, AKLI's ROE is -0.70%, compared to UPH's ROE of -1.05%. Regarding short-term risk, AKLI is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
AKLI vs UPH-WT Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, AKLI is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
AKLI vs PEARW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas PEARW's P/E ratio is -0.00. In terms of profitability, AKLI's ROE is -0.70%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, AKLI is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
AKLI vs PEAR Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas PEAR's P/E ratio is -0.08. In terms of profitability, AKLI's ROE is -0.70%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, AKLI is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
AKLI vs OTRK Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas OTRK's P/E ratio is -0.02. In terms of profitability, AKLI's ROE is -0.70%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, AKLI is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
AKLI vs HCTI Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while HCTI trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas HCTI's P/E ratio is -0.22. In terms of profitability, AKLI's ROE is -0.70%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, AKLI is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
AKLI vs CMAX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CMAX's P/E ratio is -0.00. In terms of profitability, AKLI's ROE is -0.70%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, AKLI is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
AKLI vs VSEEW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, AKLI's ROE is -0.70%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, AKLI is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check VSEEW's competition here
Aclarion, Inc. (NASDAQ: ACON)
AKLI vs ACON Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ACON's P/E ratio is -0.27. In terms of profitability, AKLI's ROE is -0.70%, compared to ACON's ROE of -0.59%. Regarding short-term risk, AKLI is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
AKLI vs LIFWZ Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, AKLI is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
AKLI vs EUDAW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, AKLI's ROE is -0.70%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, AKLI is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
AKLI vs VSEE Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas VSEE's P/E ratio is -0.10. In terms of profitability, AKLI's ROE is -0.70%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, AKLI is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
AKLI vs MSPRZ Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, AKLI is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
AKLI vs KERNW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas KERNW's P/E ratio is -0.00. In terms of profitability, AKLI's ROE is -0.70%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, AKLI is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
AKLI vs KERN Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas KERN's P/E ratio is -0.01. In terms of profitability, AKLI's ROE is -0.70%, compared to KERN's ROE of -0.20%. Regarding short-term risk, AKLI is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
AKLI vs LIFWW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas LIFWW's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, AKLI is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
AKLI vs CMAXW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CMAXW's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, AKLI is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
AKLI vs ZCMD Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ZCMD has a market cap of 35.3K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ZCMD trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, AKLI's ROE is -0.70%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, AKLI is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
AKLI vs ACONW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, ACONW has a market cap of 16K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas ACONW's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, AKLI is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
AKLI vs WGSWW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, AKLI's ROE is -0.70%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, AKLI is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check WGSWW's competition here
Cerner Corporation (NASDAQ: CERN)
AKLI vs CERN Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CERN has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CERN's P/E ratio is 55.84. In terms of profitability, AKLI's ROE is -0.70%, compared to CERN's ROE of +0.14%. Regarding short-term risk, AKLI is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check CERN's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
AKLI vs SMFRW Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas SMFRW's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, AKLI is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check SMFRW's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
AKLI vs NAVA Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas NAVA's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, AKLI is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for AKLI.Check NAVA's competition here
Castlight Health, Inc. (NYSE: CSLT)
AKLI vs CSLT Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CSLT's P/E ratio is -37.27. In terms of profitability, AKLI's ROE is -0.70%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, AKLI is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check CSLT's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
AKLI vs CHNGU Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CHNGU's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, AKLI is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CHNGU's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
AKLI vs AFFX Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas AFFX's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, AKLI is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
AKLI vs CHNG Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CHNG's P/E ratio is -152.72. In terms of profitability, AKLI's ROE is -0.70%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, AKLI is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check CHNG's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
AKLI vs MTBCO Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MTBCO's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, AKLI is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for AKLI.Check MTBCO's competition here
CareCloud, Inc. (NASDAQ: MTBC)
AKLI vs MTBC Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MTBC's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, AKLI is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MTBC's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
AKLI vs CNVY Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas CNVY's P/E ratio is -71.50. In terms of profitability, AKLI's ROE is -0.70%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, AKLI is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check CNVY's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
AKLI vs MSPRV Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MSPRV's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to MSPRV's ROE of N/A. Regarding short-term risk, AKLI is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MSPRV's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
AKLI vs KURIU Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas KURIU's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, AKLI is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check KURIU's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
AKLI vs MTBCP Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas MTBCP's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, AKLI is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check MTBCP's competition here
NantHealth, Inc. (NASDAQ: NH)
AKLI vs NH Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, NH has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas NH's P/E ratio is -0.12. In terms of profitability, AKLI's ROE is -0.70%, compared to NH's ROE of +0.35%. Regarding short-term risk, AKLI is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check NH's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
AKLI vs IMS Comparison August 2026
Akili, Inc. (NASDAQ: AKLI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AKLI stands at 34.1M. In comparison, IMS has a market cap of 0. Regarding current trading prices, AKLI is priced at $0.43 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AKLI currently has a P/E ratio of -0.71, whereas IMS's P/E ratio is N/A. In terms of profitability, AKLI's ROE is -0.70%, compared to IMS's ROE of +0.27%. Regarding short-term risk, AKLI is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for AKLI.Check IMS's competition here